Coffin described how lab workers there had transplanted
human prostate tumor cells into an immune - deficient lab mouse, a common procedure for procuring a colony of cells, or a human cell line, for further study.
Not exact matches
Researchers have injected mice with
human breast, ovary, colon, bladder, brain, liver and
prostate tumors, and their new drug has killed the
tumors every time.
Capsaicin additionally produced a significant deceleration of the development of
prostate tumors created simply by those
human cell lines grown in mouse models.
Introducing
human prostate cancer cell lines into mice, Wu and his colleagues saw a particular enzyme called MAOA activate a cascade of signals that made it easier for
tumor cells to invade and grow in bone.
They also tested other cancer lines —
human cervical, lung and
prostate cancers — and found that they responded to the patterned
tumor environments in the same way.
Using cultured cells derived from
human tumors of the breast and
prostate gland, they confirmed that the IL6R / STAT3 / miR -34 a feedback loop is also activated in other
tumor types.
Almost 10 years to the day after the
human genome sequence was completed, a group of researchers has unveiled the first whole genome sequences of
prostate tumors.
Further research uncovered a broad spectrum of cell surface stem cell markers (e.g., CD133, CD44, and CD24) that allow the identification of CSCs in
human solid
tumors, including brain, breast,
prostate, pancreas, liver, ovary, skin, colon cancers, and melanoma (3 - 6)(Figure 1 based on 7).
Although persistent loss of IGF - 1R expression ultimately induced cell stasis and death, both of these processes are regulated by the
tumor suppressor gene p53 that is commonly mutated in
human prostate cancers.
Tags: Acute Myeloid Leukemia, Andrew Hsieh, Basic Sciences, Clinical Research, Harmit Malik,
Human Biology, Jesse Bloom, Marie Bleakley,
Prostate Cancer, Transplant and Immunotherapy,
Tumor specific translational research, Vaccine development - Viral cancers
In a series of lab experiments with cell lines,
human xenograft
tumors in mice and primary
human prostate cancer samples, the researchers demonstrated that miR - 34a inhibits
prostate cancer stem cells by suppressing CD44.
Flavopiridol inhibits several cellular kinases and has demonstrated cytostatic and cytotoxic activity in vitro and in vivo in numerous
human tumor cell lines and xenograft models (including
human breast,
prostate, and lung carcinoma) at clinically achievable concentrations.
Important features of XMRV biology include (1) tropism for a variety of cell lines, including
prostate cancer DU145 and LNCaP cells [27], [43], [48], and
human neural cell types [57], (2) adaptations that promote growth in
prostate epithelium and
human - derived
prostate cancer cell lines including an androgen response element in the promoter region [58] and downregulation of APOBEC3G [59], and (3) cellular effects with potential oncogenic properties including increased
tumor aggressiveness mediated by downregulation of p27 [60] and differential regulation of several microRNAs [61].
The most frequent
tumors in
human — cancer of the colon, breast, lung, and
prostate — all involve mutations in
tumor suppressor genes.
Still, by the 1990s DuPont knew that the chemical caused cancerous
tumors in the testes, pancreases, and livers of lab animals, and there was even evidence of
human DNA damage and links to
prostate cancer in workers exposed to PFOA.
Phytates have been shown to inhibit the growth of
human leukemia cells, colon cancer cells, both estrogen receptor - positive and negative breast cancer cells, voicebox cancer, cervical cancer,
prostate cancer, liver
tumors, pancreatic, melanoma, and muscle cancers.